Randomized phase II study of the x-linked inhibitor of apoptosis (XIAP) antisense AEG35156 in combination with sorafenib in patients with advanced hepatocellular carcinoma (HCC).
Ann Sing Lee
Research Funding - Aegera Therapeutics
Benny C.Y. Zee
Research Funding - Chinese University of Hong Kong
Foon Yiu Cheung
Research Funding - Aegera Therapeutics
Philip Kwong
Research Funding - Aegera Therapeutics
Ashley Chi Kin Cheng
Research Funding - Aegera Therapeutics
Maria Lai
Research Funding - Aegera Therapeutics
Chloe Kwok
Research Funding - Aegera Therapeutics
Marc Chong
Research Funding - Aegera Therapeutics
Jacques Jolivet
Employment or Leadership Position - Aegera Therapeutics
Consultant or Advisory Role - Pharmascience
Stock Ownership - Aegera Therapeutics
Expert Testimony - Aegera Therapeutics
Other Remuneration - Aegera Therapeutics
C L Chiang
Research Funding - Aegera Therapeutics
K C Leung
Research Funding - Aegera Therapeutics
Steven Siu
Research Funding - Aegera Therapeutics
Conrad Lee
Research Funding - Aegera Therapeutics
Stewart Yuk Tung
Research Funding - Aegera Therapeutics; Aegera Therapeutics